Canopy Growth (CGC) EBITDA Margin (2019 - 2025)
Canopy Growth's (CGC) quarterly EBITDA Margin came in at 29.15% in Q4 2025, down 153.0% year-on-year from 55.0% in Q4 2024, and down 43.22% quarter-over-quarter from 20.35% in Q3 2025.
Canopy Growth (CGC) EBITDA Margin (2019 - 2025) Analysis & Trends
Canopy Growth has disclosed EBITDA Margin across 7 years of filings, most recently posting 29.15% for Q4 2025.
- EBITDA Margin for Q4 2025 came in at 29.15%, down 153.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 38.37% (up 2162.0% YoY), and the FY2025 annual result was 50.39%, up 1611.0% from the prior year.
- EBITDA Margin came in at 29.15% for Q4 2025 at Canopy Growth, down from 20.35% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 234.93% in Q2 2021 to a low of 1995.83% in Q1 2023.
- The 5-year median for EBITDA Margin is 75.06% (2021), against an average of 314.91%.
- Across the five-year window, EBITDA Margin sank 218351 bps in 2022 and jumped 190927 bps in 2023, its largest moves.
- Canopy Growth's EBITDA Margin stood at 74.04% in 2021, then slumped by 234 bps to 247.46% in 2022, then climbed by 7 bps to 231.01% in 2023, then jumped by 88 bps to 27.62% in 2024, then decreased by 6 bps to 29.15% in 2025.
- The last three EBITDA Margin figures came in at 29.15% (Q4 2025), 20.35% (Q3 2025), and 31.36% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -1.01% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 22.74% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -170.35% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 21.55% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -16.25% |
| 10 | Canopy Growth | 11.38 Mn | -137.31 Mn | 15.39 Mn | -29.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -29.15% |
| Sep 30, 2025 | -20.35% |
| Jun 30, 2025 | -31.36% |
| Mar 31, 2025 | -76.08% |
| Dec 31, 2024 | -27.62% |
| Sep 30, 2024 | -72.94% |
| Jun 30, 2024 | -38.41% |
| Mar 31, 2024 | -89.26% |
| Dec 31, 2023 | -231.01% |
| Sep 30, 2023 | -413.07% |
| Jun 30, 2023 | -39.31% |
| Mar 31, 2023 | -1,995.83% |
| Dec 31, 2022 | -247.46% |
| Sep 30, 2022 | -294.26% |
| Jun 30, 2022 | -1,948.58% |
| Mar 31, 2022 | -464.87% |
| Dec 31, 2021 | -74.04% |
| Sep 30, 2021 | 17.52% |
| Jun 30, 2021 | 234.93% |
| Mar 31, 2021 | -456.98% |